P-selectin mediates the adhesion of sickle erythrocytes to the endothelium

Blood

Volumn 98, Issue 6, 2001, Pages 1955-1962

  Matsui, Neil M ^a,b,c,d   Borsig, Lubor ^a,b,c,d   Rosen, Steven D ^a,b,c,d   Yaghmai, Mitra ^a,b,c,d   Varki, Ajit ^a,b,c,d   Embury, Stephen H ^a,b,c,d  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO STATE UNIVERSITY   (United States)

^d University of California San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY; PADGEM PROTEIN; SIALIDASE; THROMBIN;

ARTICLE; BLOOD VESSEL OCCLUSION; CELL ACTIVATION; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; SICKLE CELL; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM;

EID: 0035885941     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1955     Document Type: Article

References (83)

1. Rosen SD, Bertozzi CR. The selectins and their ligands. Curr Opin Cell Biol. 1994;6:663-673.
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
3. McEver RP, Moore KL, Cummings RD. Leukocyte trafficking mediated by selectin-carbohydrate interactions. J Biol Chem. 1995;270:11025-11028.
4. Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost. 1995;74:224-227.
5. Rosen SD, Bertozzi CR. Two selectins converge on sulphate. Leukocyte adhesion. Curr Biol. 1996;6:261-264.
6. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996;88:3259-3287.
7. Varki A. Selectin ligands: will the real ones please stand up? J Clin Invest. 1997;99:158-162.
8. Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J. Essentials of Glycobiology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999:1.
9. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101:880-886.
10. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140 a platelet α-granule membrane protein is also synthesized by vascular endothelial cells is localized in Weibel-Palade bodies. J Clin Invest. 1989;84:92-99.
11. Barkalow FJ, Goodman MJ, Gerritsen ME, Mayadas TN. Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. Blood. 1996;88:4585-4593.
12. McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest. 1997;100:S97-103.
13. Wagers AJ, Stoolman LM, Kannagi R, Craig R, Kansas GS. Expression of leukocyte fucosyltransferases regulates binding to E-selectin: relationship to previously implicated carbohydrate epitopes. J Immunol. 1997;159:1917-1929.
14. Telen MJ. Red blood cell surface adhesion molecules: their possible roles in normal human physiology and disease. Semin Hematol. 2000;37:130-142.
15. Ferrone FA, Cho MR, Bishop MF. Can a successful mechanism for HbS gelation predict sickle cell crisis? In: Beuzard Y, Charache S, Galacteros F, eds. Approaches to the Therapy of Sickle Cell Anemia. Paris: Les Editions Inserm; 1985:53-66.
16. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: rates and risk factors. N Engl J Med. 1991;325:11-16.
17. Embury SH, Hebbel RP, Mohandas N, Steinberg MH. Pathogenesis of vasoocclusion. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press; 1994:311-326.
18. Hebbel RP, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion in sickle cell disease. J Clin Invest. 1980;65:154-160.
19. Hebbel RP, Boogaerts MAB, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. N Engl J Med. 1980;302:992-995.
20. Kaul DK, Fabry ME, Nagel RL. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci U S A. 1989;86:3356-3360.
21. Wick TM, Eckman JR. Molecular basis of sickle cell-endothelial cell interactions. Curr Opin Hematol. 1996;3:118-124.
22. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest. 1997;99:2561-2564.
23. Harlan JM. Introduction: anti-adhesion therapy in sickle cell disease. Blood. 2000;95:365-367.
24. Silverstein RL. The vascular endothelium. In: Gallin JI, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. Philadelphia: Lippincott Williams & Wilkins; 1999:207-225.
25. Francis RB. Elevated fibrin D-dimer fragment in sickle cell anemia: evidence for activation of coagulation during the steady state as well as in painful crisis. Haemostasis. 1989;19:105-111.
26. Peters M, Plaat BE, ten Cate H, Wolters HJ, Weening RS, Brandjes DP. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost. 1994;71:169-172.
27. Oh SO, Ibe BO, Johnson C, Kurantsin-Mills J, Raj JU. Platelet-activating factor in plasma of patients with sickle cell disease in steady state. J Lab Clin Med. 1997;130:191-196.
28. Enwonwu CO, Lu M. Elevated plasma histamine in sickle cell anaemia. Clin Chim Acta. 1991;203:363-38.
29. Francis RB Jr, Haywood HJ. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc. 1992;84:611-615.
30. Croizat H. Circulating cytokines in sickle cell patients during steady state. Br J Haematol. 1994;87:592-597.
31. Taylor SC, Shacks SJ, Qu Z. In vivo production of type 1 cytokines in healthy sickle cell disease patients. J Natl Med Assoc. 1999;91:619-24.
32. Sherwood JB, Goldwasser E, Chilcote R, Carmichael LD, Nagel RL. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood. 1986;67:46-48.
33. SoloveyA, Gui L, Ramakrishnan S, Steinberg MH, Hebbel RP. Sickle cell anemia as a possible state of enhanced anti-apoptotic tone: survival effect of vascular endothelial growth factor on circulating and unanchored endothelial cells. Blood. 1999;93:3824-3830.
34. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood. 1996;88:2311-2320.
35. Inwald DP, Kirkham FJ, Peters MJ, et al. Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol. 2000;111:474-481.
36. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest. 2000;106:411-420.
37. Rank BH, Carlsson J, Hebbel RP. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest. 1985;75:1531-1537.
38. Hebbel RP, Visser MR, Goodman JL, Jacob HS, Vercellotti GM. Potentiated adherence of sickle erythrocytes to endothelium infected by virus. J Clin Invest. 1987;80:1503-1506.
39. Shiu YT, Udden MM, McIntire LV. Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells. Blood. 2000;95:3232-3241.
40. Nadeau K, Gee B, Jennette JC, Tilney N, Trudel M, Platt OS. Increased inflammatory and endothelial cell factors in tissues from humans and mice with sickle cell disease [abstract]. Blood. 1997;90(suppl 1):125A.
41. Duits AJ, Pieters RC, Saleh AW, et al. Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin Immunol Immunopathol. 1996;81:96-98.
42. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1584-1589.
43. Solovey A, Gui L, Key NS, Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest. 1998;101:1899-1904.
44. Kaul DK, Tsai HM, Liu XD, Nakada MT, Nagel RL, Coller BS. Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood. 2000;95:368-374.
45. Hebbel RP. Clinical implications of basic research: blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. N Engl J Med. 2000;342:1910-1912.
46. Manodori AB, Matsui NM, Chen JY, Embury SH. Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation. Blood. 1998;92:3445-3454.
47. Koenig A, Norgard-Sumnicht K, Linhardt R, Varki A. Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest. 1998;101:877-889.
48. Patel N, Brinkman-Van der Linden EC, Altmann SW, et al. OB-BP1/Siglec-6: a leptin- and sialic acid-binding protein of the immunoglobulin superfamily [published erratum appears in J Biol Chem 1999 Sept 24;274(39):28058]. J Biol Chem. 1999;274:22729;22738.
49. Angata T, Varki A. Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily. Glycobiology. 2000;10:431-438.
50. Rosen SD, Singer MS, Yednock TA, Stoolman LM. Involvement of sialic acid on endothelial cells in organ-specific lymphocyte recirculation. Science. 1985;228:1005-1007.
51. Issitt PD. Applied Blood Group Serology. Miami, FL: Montgomery Scientific Publications; 1985:50.
52. Conover WJ. Practical Nonparametric Statistics. New York: John Wiley & Sons; 1980:1.
53. Beckstead JH, Stenberg PE, McEver RP, Shuman MA, Bainton DF. Immunohistochemical localization of membrane α-granule proteins in human megakaryocytes: application to plastic-embedded bone marrow biopsy specimens. Blood. 1986;67:285-293.
54. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 2000;95:1293-1300.
55. Ho M, Schollaardt T, Niu X, Looareesuwan S, Patel KD, Kubes P. Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions. Blood. 1998;91:4803-4809.
56. Yipp BG, Anand S, Schollaardt T, Patel KD, Looareesuwan S, Ho M. Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood. 2000;96:2292-2298.
57. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med. 1997;129:507-516.
58. Hofstra TC, Kalra VK, Meiselman HJ, Coates TD. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood. 1996;87:4440-4447.
59. Fadion E, Vordermeier S, Pearson TC, et al. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood. 1998;91:266-274.
60. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Sickle cell interactions with adherent leukocytes can initiate venular occlusion in sickle cell mice [abstract]. Blood. 2000;96(suppl 1):528A.
61. Olson PS, Ljungqvist U, Bergentz SE. Analysis of platelet, red cell and fibrin content in experimental arterial and venous thrombi. Thromb Res. 1974;5:1-19.
62. Sevitt S. The structure and growth of valve-pocket thrombi in femoral veins. J Clin Pathol. 1974;27:517-28.
63. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762-769.
64. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859-873.
65. Chen S, Springer TA. An automatic braking system that stabilizes leukocyte rolling by an increase in selectin bond number with shear. J Cell Biol. 1999;144:185-200.
66. van der Merwe PA. Leukocyte adhesion: high-speed cells with ABS. Curr Biol. 1999;9:R419-R22.
67. Paszty C, Brion CM, Manci E, et al. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science. 1997;278:876-878.
68. Embury SH, Mohandas N, Paszty C, Cooper P, Cheung ATW. In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. J Clin Invest. 1999;103:915-920.
69. Roberts DD, Ginsburg V. Sulfated glycolipids and cell adhesion. Arch Biochem Biophys. 1988;267:405-415.
70. Aruffo A, Kolanus W, Walz G, Fredman P, Seed B. CD62/P-selection recognition of myeloid and tumor cell sulfatides. Cell. 1991;67:35-44.
71. Serra MV, Mannu F, Matera A, Turrini F, Arese P. Enhanced IgG- and complement-independent phagocytosis of sulfatide-enriched human erythrocytes by human monocytes. FEBS Lett. 1992;311:67-70.
72. Needham LK, Schnaar RL. The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc Natl Acad Sci U S A. 1993;90:1359-1363.
73. Roberts DD, Rao CN, Liotta LA, Gralnick HR, Ginsburg V. Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. J Biol Chem. 1986;261:6872-6877.
74. Hillery CA, Du MC, Montgomery RR, Scott JP. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood. 1996;87:4879-4886.
75. Somers WS, Tang J, Shaw GD, Camphausen RT. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P-and E-selectin bound to SLe(X) and PSGL-1. Cell. 2000;103:467-79.
76. Henry S, Oriol R, Samuelsson B. Lewis histoblood group system and associated secretory phenotypes. Vox Sang. 1995;69:166-182.
77. Parsons SF, Spring FA, Chasis JA, Anstee DJ. Erythroid cell adhesion molecules Lutheran and LW in health and disease. Baillieres Best Pract Res Clin Haematol. 1999;12:729-45.
78. Southcott MJ, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood. 1999;93:4425-435.
79. Bernatowicz MS, Klimas CE, Hartl KS, Peluso M, Allegretto NJ, Seiler SM. Development of potent thrombin receptor antagonist peptides. J Med Chem. 1996;39:4879-4887.
80. Lowe JB, Ward PA. Therapeutic inhibition of carbohydrate-protein interactions in vivo. J Clin Invest. 1997;99:822-826.
81. Nelson RM, Cecconi O, Roberts WG, Aruffo A, Linhardt RJ, Bevilacqua MP. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood. 1993;82:3253-3258.
82. Gupta K, Gupta P, SoloveyA, Hebbel RP. Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin. Biochim Biophys Acta. 1999;1453:63-73.
83. Chaplin H Jr, Monroe MC, Malecek AC, Morgan LK, Michael J, Murphy WA. Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises. East Afr Med J. 1989;66:574-584.